PHLDA3 Antibodies

Santa Cruz Biotechnology offers a broad range of PHLDA3 monoclonal antibodies for various research applications. PHLDA3 Antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PHLDA3, or Pleckstrin Homology-Like Domain, Family A, Member 3, plays a critical role in regulating cell survival and apoptosis, making it significant in cancer research and developmental biology. PHLDA3 expression levels can influence cellular responses to stress and contribute to the understanding of various diseases, including cancer. The study of PHLDA3 is essential for elucidating mechanisms of tumorigenesis and potential therapeutic targets. Researchers worldwide utilize PHLDA3 monoclonal antibodies to investigate cellular pathways and molecular mechanisms. PHLDA3 monoclonal antibodies enable precise detection and analysis of protein expression patterns in diverse experimental settings. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific knowledge and developing potential therapeutic strategies for cancer and other diseases.